FDA Inspection 1156954 — ImpactLife
The FDA completed an inspection of ImpactLife on Nov 12, 2021 in Coralville, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 12, 2021
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Coralville, IA (United States)